Abstract
In manuscript we analyzed the literature review of the stem cells application for the treatment of ischemic
heart disease including the results of experimental stem cells studies and their molecular mechanisms action
in the myocardium regeneration. The main topic was attended to therapeutic potential of the induced
pluripotent stem cells for the treatment of various diseases, with special attention to data on the immunogenicity of these cells.
We also analyze the data from clinical trials for the use of stem cells in combination with transmyocardial
laser revascularization in patient with diffuse coronary heart disease. This stimulation of angiogenesis may be
induced by intramyocardial administration of autologous bone marrow stem cells, and then intensified by
inflammation caused by laser exposure.
References
1.
Бокерия Л.А., Алекян Б.Г., Коломбо А., Бузиашви-
ли Ю.И.
Интервенционные методы лечения
ишемической болезни сердца. М.: НЦССХ им.
А.Н. Бакулева РАМН; 2002: 9.
2.
Бокерия Л.А., Голухова Е.З., Какучая Т.Т.
Ре¬
зультаты клинических исследований с исполь¬
зованием клеточных технологий в лечении па¬
циентов с застойной сердечной недостаточнос¬
тью.
Бюллетень НЦССХ им. А.Н. Бакулева
РАМН.
2006; 7 (6, Прилож.): 296.
3.
Бокерия Л.А., Беришвили И.И., Сигаев И.Ю., Ас-
ланиди И.П., Вахромеева М.Н., Мерзляков В.Ю.
и др. 500 операций трансмиокардиальной ла¬
зерной реваскуляризации (ТМЛР) — каковы ре¬
зультаты?
Бюллетень НЦССХ им. А.Н. Бакулева
РАМН.
2007; 8 (6, Прилож.): 72.
4.
Бокерия Л.А., Беришвили И.И., Вахромеева М.Н.,
Сарджвеладзе Э.Г., Солнышков И.В., Вахрамее¬
ва А.Ю.
Терапевтический ангиогенез в лечении
больных ИБС. Взгляд клинициста.
Бюллетень
НЦССХ им. А.Н. Бакулева РАМН.
2008; 9 (3):
52-63.
5.
БокерияЛ.А., Никонов С.Ф., Бенделиани Н.Г., Че-
ишвили З.М., Крымов К.В.
Эффективность
и влияние многофакторного подхода к лече¬
нию больных ишемической болезнью сердца
после изолированного коронарного шунтиро¬
вания и его сочетания с геометрической рекон¬
струкцией левого желудочка на качество жизни
и потребность в госпитализациях (результаты
12-месячного рандомизированного клиничес¬
кого исследования).
Анналы аритмологии.
2011;
4: 43-53.
6.
Aaberge L., Nordstrand K., Dragsund M., Saatvedt K.,
Endresen K., Golf S.
Transmyocardial revasculariza¬
tion with CO2 laser in patients with refractory angi¬
na pectoris: clinical results from the Norwegian ran¬
domized trial.
J. Am. Coll. Cardiol.
2000; 35:
1170-7.
7.
LosordoD.W., SchatzR.A., WhiteC.J., Udelson J.E.,
Veereshwarayya V., Durgin M.
Intramyocardial
transplantation of autologous CD34+ stem cells for
intractable angina: a phase I/IIa double-blind, ran¬
domized controlled trial.
Circulation.
2007; 115:
3165-72.
8.
Singla D.K., Singla R.D., McDonald D.E.
Factors
released from embryonic stem cells inhibit apopto¬
sis in H9c2 cells through PI3K/Akt but not ERK
pathway.
Am. J. Physiol. Heart Circ. Physiol.
2008;
295: 907-13.
9.
Burkhoff D., Schmidt S., Schulman S.P., Myers J.,
Resar J., Becker L.C.
Transmyocardial laser revas¬
cularization compared with continued medical
therapy for treatment of refractory angina pectoris:
a prospective randomised trial. ATLANTIC
Investigators Angina Treatment: Laser and normal
therapies in comparison.
Lancet.
1999; 354:
885-90.
10.
Jeevanantham V., Butler M., Saad A., Dawn B.,
Abdel-Latif A., Zuba-Surma E.K.
Adult bone mar¬
row cell therapy improves survival and induces long¬
term improvement in cardiac parameters: a syste¬
matic review and meta-analysis.
Circulation.
2012;
126: 551-68.
11.
Takahashi K., Yamanaka S.
Induction of pluripo-
tent stem cells from mouse embryonic and adult
fibroblast cultures by defined factors.
Cell.
2006;
126: 663-76.
12.
Hendrikx M., Hensen K., Clijsters C., Jongen H.,
Koninckx R., Bijnens E.
Recovery of regional but not
global contractile function by the direct intramyo¬
cardial autologous bone marrow transplantation:
results from a randomized controlled clinical trial.
Circulation.
2006; 114: 101-7.
13.
Miyahara Y., Nagaya N., Kataoka M., Yanagawa B.,
Tanaka K., Hao H.
Monolayered mesenchymal
stem cells repair scarred myocardium after myocar¬
dial infarction.
Nat. Med.
2006; 12: 459-65.
14.
Qiao H., Zhang H., Zheng Y., Ponde D.E., Shen D.,
Gao F.
Embryonic stem cell grafting in normal and
infarcted myocardium: serial assessment with MR
imaging and PET dual detection.
Radiology.
2009;
250: 821-9.
15.
Lowry W.E., Richter L., Yachechko R., Pyle A.D.,
Tchieu J., Sridharan R.
Generation of human
induced pluripotent stem cells from dermal fibro¬
blasts.
Proc. Nat. Acad. Sci. USA.
2008; 105; 2883-8.
16.
Mukherjee D., Bhatt D.L., Roe M .T., Patel V.,
Ellis S.G.
Direct myocardial revascularization and
angiogenesis. How many patients might be eligible?
Am. J. Cardiol.
1999; 84: 598-600.
17.
Strauer B.E., Brehm M., Zeus T., Bartsch T.,
Schannwell C., Antke C.
Regeneration of human
infarcted heart muscle by intracoronary autologous
bone marrow cell transplantation in chronic coro¬
nary artery disease: the IACT Study.
J. Am. Coll.
Cardiol.
2005; 46: 1651-8.
18.
Losordo D.W., Henry T.D., Davidson C., Sup Lee J.,
Costa M.A., Bass T.
Intramyocardial, autologous
CD34+ cell therapy for refractory angina.
Circ. Res.
2011; 109: 428-36.
19.
Schachinger V., Erbs S., Elsasser A., Haber-
bosch W., Hambrecht R., Holschermann H.
Intracoronary bone marrow-derived progenitor
cells in acute myocardial infarction.
N. Engl. J.
Med.
2006; 355: 1210-21.
20.
Oshima Y., Ouchi N., Sato K., Izumiya Y., Pimen¬
tel D.R., Walsh K.
Follistatin-like 1 is an Akt-regu-
lated cardioprotective factor that is secreted by the
heart.
Circulation.
2008; 117: 3099-108.
21.
Bruns kill S.J., Hyde C.J., Doree C.J., Watt S.M.,
Martin-Rendon E.
Route of delivery and baseline
left ventricular ejection fraction, key factors of
bone-marrow-derived cell therapy for ischaemic
heart disease.
Eur. J. Heart Fail.
2009; 11: 887-96.
22.
Mirotsou M., Zhang Z., Deb A., Zhang L., Gnec-
chi M., Noiseux N.
Secreted frizzled related prote¬
in 2 (Sfrp2) is the key Akt-mesenchymal stem cell-
released paracrine factor mediating myocardial sur¬
vival and repair.
Proc. Nat. Acad. Sci. USA.
2007;
104: 1643-8.
stem cells: a new era for hepatology.
J. Hepatol.
2010; 53: 738-51.
37.
Passier R., Van Laake L.W., Mummery C.L.
Stem¬
cell-based therapy and lessons from the heart.
Nature.
2008; 453: 322-9.
38.
Perin E.C., Silva G.V., Henry T.D., Cabreira-Han-
sen M.G., Moore W.H., Coulter S.A.
A randomized
study of transendocardial injection of autologous
bone marrow mononuclear cells and cell
function analysis in ischemic heart failure
(FOCUS-HF).
Am. Heart J.
2011; 161: 1078-87.
39.
Clifford D.M., Fisher S.A., Brunskill S.J., Doree C.,
Mathur A., Watt S.
Stem cell treatment for acute
myocardial infarction.
Cochrane Database Syst. Rev.
2012; 2: 006536.
40.
Mummery C., Ward-van Oostwaard D., Doeven-
dans P., Spijker R., van den Brink S., Hassink R.
Differentiation of human embryonic stem cells to
cardiomyocytes: role of coculture with visceral endo-
derm-like cells.
Circulation.
2003; 107: 2733-40.
41.
Perin E.C., Silva G.V., Zheng Y., Gahremanpour A.,
Canales J., PatelD.
Randomized, double-blind pilot
study of transendocardial injection of autologous
aldehyde dehydrogenase-bright stem cells in
patients with ischemic heart failure.
Am. Heart J.
2012; 163: 415-21.
42.
Perin E.C., Willerson J.T., Pepine C.J., Henry T.D.,
Ellis S.G., Zhao D.X.
Effect of transendocardial
delivery of autologous bone marrow mononuclear
cells on functional capacity, left ventricular func¬
tion, and perfusion in chronic heart failure: the
FOCUS-CCTRN trial.
JAMA.
2012; 307: 1717-26.
43.
Bhuiyan M.S., Shioda N., Fukunaga K.
Targeting
protein kinase B/Akt signaling with vanadium com¬
pounds for cardioprotection.
Expert Opin. Ther.
Targets.
2008; 12: 1217-27.
44.
Tang Y., Zheng J., Sun Y., Wu Z., Liu Z., Huang G.
MicroRNA-1 regulates cardiomyocyte apoptosis by
targeting Bcl-2.
Int. Heart J.
2009; 50: 377-87.
45.
Diegeler A., Cheng D., Allen K.
Transmyocardial
laser revascularization: a consensus statement of the
International Society of Minimally Invasive
Cardiothoracic Surgery (ISMICS).
Innovations
(Phila).
2006; 1: 314-22.
46.
Di Mauro M., Iaco A.L., Contini M., Teodori G.,
Vitolla G., Pano M.
Reoperative coronary artery
bypass grafting: analysis of early and late outcomes.
Ann. Thorac. Surg.
2005; 79: 81-7.
47.
Nelson T.J., Martinez-Fernandez A., Yamada S.,
Perez-Terzic C., Ikeda Y., Terzic A.
Repair of acute
myocardial infarction by human stemness factors
induced pluripotent stem cells.
Circulation.
2009;
120: 408-16.
48.
Shan Z.X., Lin Q.X., Fu Y .H , Deng C.Y., Zhou Z.L.,
Zhu J.N.
Upregulated expression of miR-1/miR-206
in a rat model of myocardial infarction.
Biochem.
Biophys. Res. Commun.
2009; 381: 597-601.
49.
Hanna J., Wernig M., Markoulaki S.
Treatment of
sickle cell anemia mouse model with iPS cells ge¬
nerated from autologous skin.
Science.
2007; 318:
1920-3.